title: Adipokines and adipocyte targets in the future management of obesity and the metabolic syndrome.
abstract: The role of adipocytes has been recently better understood. Several adipocytokines have been identified, including leptin, a main regulator of appetite and energy expenditure, adiponectin and others, as novel insulin-sensitizers/insulin-mimetics, and some others inducing insulin resistance. Adipocytokines thus represent interesting novel drug targets in the future management of obesity.
authors.affiliation: Department of Internal Medicine, University of Leipzig, Leipzig, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Kralisch
authors.forename: M
authors.initials: M
authors.lastname: Bluher
authors.forename: R
authors.initials: R
authors.lastname: Paschke
authors.forename: M
authors.initials: M
authors.lastname: Stumvoll
authors.forename: M
authors.initials: M
authors.lastname: Fasshauer
mesh_terms: D017667:Adipocytes / Q000378:metabolism*; D001067:Appetite Depressants / Q000494:pharmacology; D006801:Humans; D007333:Insulin Resistance; D024821:Metabolic Syndrome / Q000188:drug therapy*; D009765:Obesity / Q000188:drug therapy*; D036361:Peptide Hormones / Q000378:metabolism* / Q000494:pharmacology
chemical_list: D001067:Appetite Depressants; D036361:Peptide Hormones